GENE ONLINE|News &
Opinion
Blog

Leqembi
The 2025 Alzheimer’s Drug Pipeline: Market Projections and Clinical Breakthroughs
2025-09-02
Leqembi Makes History as First EU-Approved Drug to Target Root Cause of Alzheimer’s Disease
2025-04-15
Advancements in Alzheimer’s Disease Drug Innovation and Funding Programs in 2024
2024-07-04
GeneOnline’s Pick – Top 10 Global Industry News Stories in 2023 (Part 2)
2024-01-15
GeneOnline’s Weekly News Highlights: Oct 22-Oct 27
2023-10-31
FDA Granted Eisai and Biogen’s New Alzheimer’s Drug a Traditional Approval, Making Medicare Coverage Possible
2023-07-11
LATEST
Blinatumomab Linked to Epstein-Barr Virus Reactivation in Pre-Allogeneic Stem Cell Transplant Patients
2026-01-23
Unified Framework Combining U-Net++ and CNN-RNN-BiGRU Developed for Automated Weed Detection in Agriculture
2026-01-23
Study Explores Use of EHR Portals for Collecting Advance Directives and Surrogate Information
2026-01-23
Urban Mice Exhibit Faster Problem-Solving Skills Compared to Protected Area Counterparts
2026-01-23
Study Finds High Turnover Intentions Among Nurses in Tertiary Care Settings Due to Workplace Stress and Limited Career Growth
2026-01-23
Early Detection and Genetic Testing Highlighted as Key Strategies for Managing Hereditary Hemorrhagic Telangiectasia
2026-01-23
Vietnamese Researchers Use Machine Learning with M-CHAT-R and Perinatal Data to Improve Autism Risk Identification in Toddlers
2026-01-23
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
Scroll to Top